Predictors of clinical response of non-small cell cancer to gefitinib - Reply Journal Article


Authors: Ardizzoni, A.; Tiseo, M.; Kris, M. G.; Kay, A. C.; Ochs, J. J.; Wolf, M. K.
Article Title: Predictors of clinical response of non-small cell cancer to gefitinib - Reply
Keywords: immunohistochemistry; treatment outcome; disease course; histopathology; antineoplastic agents; note; antineoplastic agent; letter; adenocarcinoma; lung non small cell cancer; carcinoma, non-small-cell lung; lung neoplasms; epidermal growth factor receptor; receptor, epidermal growth factor; drug effect; enzyme inhibitor; prediction; docetaxel; lung tumor; drug antagonism; enzyme inhibitors; gefitinib; gender; quinazolines; quinazoline derivative; cisplatin derivative; endothelial cell growth factor; humans; prognosis; human; priority journal
Journal Title: JAMA - Journal of the American Medical Association
Volume: 291
Issue: 13
ISSN: 0098-7484
Publisher: American Medical Association  
Date Published: 2004-04-07
Start Page: 1563
End Page: 1564
Language: English
PUBMED: 15069041
PROVIDER: scopus
DOI: 10.1001/jama.291.13.1563-b
DOI/URL:
Notes: Export Date: 16 June 2014 -- CODEN: JAMAA -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark Kris
    869 Kris